Cancer research at RCSI
RCSI cancer researchers – in collaboration with industry and our clinical sites – are discovering new ways to improve outcomes for cancer patients by optimising prevention, diagnosis and therapy.
We study a wide variety of cancer types, with a particular focus on breast, neuroblastoma, brain, ovarian and colorectal cancer. We aim to determine the causes of cancer at the molecular level in order to identify targets for the development of new therapies. We are also identifying novel biomarkers for diagnosis and predicting response to current therapies.Read our impact stories
"RCSI carries out research that brings maximum benefit to cancer patients and ensures that Ireland is at the forefront of excellent patient care now and in the future."
Networks and collaborations
RCSI plays a leading role in a number of large collaborative cancer research programmes and clinical trials, involving partners from industry, academia and clinical organisations. These networks allow us to use cutting-edge technologies and international expertise to better understand cancer biology and find new ways to treat it.
An innovative collaboration between RCSI, Beaumont Hospital, and St Luke’s Radiation Oncology Network. Accredited by the Organisation European Cancer Institutes.
A precision oncology therapeutics spin-out company that is developing targeted treatments for breast cancer brain metastatic patients.